Newron Pharmaceuticals SpA (NWRN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.119x

Based on the latest financial reports, Newron Pharmaceuticals SpA (NWRN) has a cash flow conversion efficiency ratio of 0.119x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.33 Million ≈ $-1.68 Million USD) by net assets (CHF-11.13 Million ≈ $-14.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Newron Pharmaceuticals SpA (NWRN) defensive interval to measure how many days the company can operate on defensive assets alone.

Newron Pharmaceuticals SpA - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Newron Pharmaceuticals SpA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Newron Pharmaceuticals SpA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Newron Pharmaceuticals SpA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Kaichuang Marine International Co Ltd SHG:600097	0.041x
Shandong Teamgene Technology Co. Ltd. A SHG:603151	N/A
Fabryka Farb i Lakierów ŚNIEŻKA SA WAR:SKA	0.114x
Dalmia Bharat Sugar and Industries Limited NSE:DALMIASUG	0.249x
Duopharma Biotech Bhd KLSE:7148	0.033x
Organogenesis Holdings Inc NASDAQ:ORGO	0.008x
Nivika Fastigheter AB Series B ST:NIVI-B	0.010x
Provident Agro Tbk JK:PALM	0.279x

Annual Cash Flow Conversion Efficiency for Newron Pharmaceuticals SpA (2005–2025)

The table below shows the annual cash flow conversion efficiency of Newron Pharmaceuticals SpA from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Newron Pharmaceuticals SpA stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-11.13 Million ≈ $-14.07 Million	CHF32.56 Million ≈ $41.17 Million	-2.926x	+75.78%
2024-12-31	CHF1.46 Million ≈ $1.84 Million	CHF-17.61 Million ≈ $-22.27 Million	-12.081x	-3663.28%
2023-12-31	CHF-29.91 Million ≈ $-37.81 Million	CHF-10.14 Million ≈ $-12.82 Million	0.339x	-57.12%
2022-12-31	CHF-14.03 Million ≈ $-17.74 Million	CHF-11.09 Million ≈ $-14.02 Million	0.791x	+121.46%
2021-12-31	CHF3.11 Million ≈ $3.93 Million	CHF-11.45 Million ≈ $-14.47 Million	-3.684x	-307.54%
2020-12-31	CHF17.25 Million ≈ $21.80 Million	CHF-15.59 Million ≈ $-19.71 Million	-0.904x	-51.35%
2019-12-31	CHF36.80 Million ≈ $46.52 Million	CHF-21.98 Million ≈ $-27.78 Million	-0.597x	-105.27%
2018-12-31	CHF54.84 Million ≈ $69.33 Million	CHF-15.95 Million ≈ $-20.17 Million	-0.291x	-134.45%
2017-12-31	CHF67.72 Million ≈ $85.62 Million	CHF-8.40 Million ≈ $-10.62 Million	-0.124x	+68.48%
2016-12-31	CHF49.75 Million ≈ $62.89 Million	CHF-19.58 Million ≈ $-24.76 Million	-0.394x	-13.58%
2015-12-31	CHF37.11 Million ≈ $46.92 Million	CHF-12.86 Million ≈ $-16.26 Million	-0.347x	-1.43%
2014-12-31	CHF29.26 Million ≈ $36.99 Million	CHF-10.00 Million ≈ $-12.64 Million	-0.342x	+32.56%
2013-12-31	CHF21.09 Million ≈ $26.66 Million	CHF-10.69 Million ≈ $-13.51 Million	-0.507x	-340.15%
2012-12-31	CHF27.61 Million ≈ $34.90 Million	CHF5.83 Million ≈ $7.36 Million	0.211x	+128.11%
2011-12-31	CHF6.58 Million ≈ $8.33 Million	CHF-4.94 Million ≈ $-6.25 Million	-0.750x	+52.17%
2010-12-31	CHF12.19 Million ≈ $15.41 Million	CHF-19.13 Million ≈ $-24.18 Million	-1.569x	-99.27%
2009-12-31	CHF29.28 Million ≈ $37.02 Million	CHF-23.06 Million ≈ $-29.15 Million	-0.787x	-80.96%
2008-12-31	CHF45.81 Million ≈ $57.92 Million	CHF-19.93 Million ≈ $-25.20 Million	-0.435x	-80.11%
2007-12-31	CHF57.40 Million ≈ $72.57 Million	CHF-13.87 Million ≈ $-17.53 Million	-0.242x	-70.22%
2006-12-31	CHF67.86 Million ≈ $85.79 Million	CHF-9.63 Million ≈ $-12.17 Million	-0.142x	+83.14%
2005-12-31	CHF17.02 Million ≈ $21.52 Million	CHF-14.33 Million ≈ $-18.12 Million	-0.842x	--

About Newron Pharmaceuticals SpA

SW:NWRN Switzerland Biotechnology

Market Cap

$316.70 Million

CHF250.50 Million CHF

Market Cap Rank

#14986 Global

#155 in Switzerland

Share Price

CHF12.04

Change (1 day)

+0.17%

52-Week Range

CHF6.66 - CHF30.40

All Time High

CHF30.40